{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:32:52Z","timestamp":1791196372044,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,6,15]],"date-time":"2013-06-15T00:00:00Z","timestamp":1371254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00406-013-0413-4","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T06:39:26Z","timestamp":1371191966000},"page":"179-183","source":"Crossref","is-referenced-by-count":50,"title":["Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate"],"prefix":"10.1007","volume":"264","author":[{"given":"Guillaume","family":"Fond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Macgregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryad","family":"Tamouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Hamdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Meary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Leboyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Dubremetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,15]]},"reference":[{"key":"413_CR1","first-page":"31","volume":"6","author":"A Alipour","year":"2011","unstructured":"Alipour A, Shojaee S, Mohebali M, Tehranidoost M, Abdi Masoleh F, Keshavarz H (2011) Toxoplasma infection in schizophrenia patients: a comparative study with control group. Iran J Parasitol 6:31\u201337","journal-title":"Iran J Parasitol"},{"key":"413_CR2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.schres.2011.10.026","volume":"136","author":"I Arias","year":"2012","unstructured":"Arias I, Sorlozano A, Villegas E, de Dios Luna J, McKenney K, Cervilla J, Gutierrez B, Gutierrez J (2012) Infectious agents associated with schizophrenia: a meta-analysis. Schizophr Res 136:128\u2013136","journal-title":"Schizophr Res"},{"key":"413_CR3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/schbul\/sbq146","volume":"37","author":"AS Brown","year":"2011","unstructured":"Brown AS, Patterson PH (2011) Maternal infection and schizophrenia: implications for prevention. Schizophr Bull 37:284\u2013290","journal-title":"Schizophr Bull"},{"key":"413_CR4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00436-009-1526-6","volume":"105","author":"RC Silva da","year":"2009","unstructured":"da Silva RC, Langoni H (2009) Toxoplasma gondii: host-parasite interaction and behavior manipulation. Parasitol Res 105:893\u2013898","journal-title":"Parasitol Res"},{"key":"413_CR5","first-page":"151","volume":"29","author":"O Emelia","year":"2012","unstructured":"Emelia O, Amal RN, Ruzanna ZZ, Shahida H, Azzubair Z, Tan KS, Noor Aadila S, Siti NA, Aisah MY (2012) Seroprevalence of anti-Toxoplasma gondii IgG antibody in patients with schizophrenia. Trop Biomed 29:151\u2013159","journal-title":"Trop Biomed"},{"key":"413_CR6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/schbul\/sbl074","volume":"33","author":"J Flegr","year":"2007","unstructured":"Flegr J (2007) Effects of Toxoplasma on human behavior. Schizophr Bull 33:757\u2013760","journal-title":"Schizophr Bull"},{"key":"413_CR7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.encep.2012.06.014","volume":"39","author":"G Fond","year":"2013","unstructured":"Fond G, Capdevielle D, Macgregor A, Attal J, Larue A, Brittner M, Ducasse D, Boulenger JP (2013) Toxoplasma gondii: a potential role in the genesis of psychiatric disorders. Encephale 39:38\u201343","journal-title":"Encephale"},{"key":"413_CR8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1645\/GE-2536.1","volume":"97","author":"DG Goodwin","year":"2011","unstructured":"Goodwin DG, Strobl JS, Lindsay DS (2011) Evaluation of five antischizophrenic agents against Toxoplasma gondii in human cell cultures. J Parasitol 97:148\u2013151","journal-title":"J Parasitol"},{"key":"413_CR9","unstructured":"Hamdani N, Daban-Huard C, Lajnef M, Richard JR, Delavest M, Godin O, Guen EL, Vederine FE, Lepine JP, Jamain S, Houenou J, Corvoisier PL, Aoki M, Moins-Teisserenc H, Charron D, Krishnamoorthy R, Yolken R, Dickerson F, Tamouza R, Leboyer M (2012) Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. J Affect Disord 148(2\u20133):444\u2013448"},{"key":"413_CR10","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.2741\/e534","volume":"4","author":"N Hamdani","year":"2012","unstructured":"Hamdani N, Tamouza R, Leboyer M (2012) Immuno-inflammatory markers of bipolar disorder: a review of evidence. Front Biosci (Elite Ed) 4:2170\u20132182","journal-title":"Front Biosci (Elite Ed)"},{"key":"413_CR11","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/schbul\/sbm010","volume":"33","author":"D Hinze-Selch","year":"2007","unstructured":"Hinze-Selch D, Daubener W, Eggert L, Erdag S, Stoltenberg R, Wilms S (2007) A controlled prospective study of Toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence. Schizophr Bull 33:782\u2013788","journal-title":"Schizophr Bull"},{"key":"413_CR12","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1128\/AAC.38.6.1392","volume":"38","author":"E Holfels","year":"1994","unstructured":"Holfels E, McAuley J, Mack D, Milhous WK, McLeod R (1994) In vitro effects of artemisinin ether, cycloguanil hydrochloride (alone and in combination with sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondii. Antimicrob Agents Chemother 38:1392\u20131396","journal-title":"Antimicrob Agents Chemother"},{"key":"413_CR13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0920-9964(02)00357-2","volume":"62","author":"L Jones-Brando","year":"2003","unstructured":"Jones-Brando L, Torrey EF, Yolken R (2003) Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res 62:237\u2013244","journal-title":"Schizophr Res"},{"key":"413_CR14","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.micinf.2008.07.015","volume":"10","author":"K Kim","year":"2008","unstructured":"Kim K, Weiss LM (2008) Toxoplasma: the next 100\u00a0years. Microbes Infect 10:978\u2013984","journal-title":"Microbes Infect"},{"key":"413_CR15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jchromb.2006.05.031","volume":"843","author":"H Kirchherr","year":"2006","unstructured":"Kirchherr H, Kuhn-Velten WN (2006) Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by hplc tandem mass spectrometry: a multi-level, single-sample approach. J Chromatogr B Analyt Technol Biomed Life Sci 843:100\u2013113","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"413_CR16","doi-asserted-by":"crossref","unstructured":"Leboyer M, Tamouza R, Charron D, Faucard R, Perron H (2011) Human endogenous retrovirus type w (herv-w) in schizophrenia: a new avenue of research at the gene-environment interface. World J Biol Psychiatry","DOI":"10.3109\/15622975.2010.601760"},{"key":"413_CR17","doi-asserted-by":"crossref","unstructured":"Nascimento FS, de Rosalmeida Dantas C, Netto MP, Mella LF, Suzuki LA, Banzato CE, Rossi CL (2012) Prevalence of antibodies to Toxoplasma gondii in patients with schizophrenia and mood disorders. Schizophr Res","DOI":"10.1016\/j.schres.2012.08.036"},{"key":"413_CR18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.schres.2011.08.006","volume":"133","author":"O Okusaga","year":"2011","unstructured":"Okusaga O, Langenberg P, Sleemi A, Vaswani D, Giegling I, Hartmann AM, Konte B, Friedl M, Groer MW, Yolken RH, Rujescu D, Postolache TT (2011) Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr Res 133:150\u2013155","journal-title":"Schizophr Res"},{"key":"413_CR19","doi-asserted-by":"crossref","first-page":"e23866","DOI":"10.1371\/journal.pone.0023866","volume":"6","author":"E Prandovszky","year":"2011","unstructured":"Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, McConkey GA (2011) The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One 6:e23866","journal-title":"PLoS One"},{"key":"413_CR20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1017\/S0031182006000886","volume":"133","author":"A Skallova","year":"2006","unstructured":"Skallova A, Kodym P, Frynta D, Flegr J (2006) The role of dopamine in Toxoplasma-induced behavioural alterations in mice: an ethological and ethopharmacological study. Parasitology 133:525\u2013535","journal-title":"Parasitology"},{"key":"413_CR21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/00034983.1985.11811902","volume":"79","author":"HH Stibbs","year":"1985","unstructured":"Stibbs HH (1985) Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol 79:153\u2013157","journal-title":"Ann Trop Med Parasitol"},{"key":"413_CR22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/schbul\/sbl050","volume":"33","author":"EF Torrey","year":"2007","unstructured":"Torrey EF, Bartko JJ, Lun ZR, Yolken RH (2007) Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 33:729\u2013736","journal-title":"Schizophr Bull"},{"key":"413_CR23","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/schbul\/sbs043","volume":"38","author":"EF Torrey","year":"2012","unstructured":"Torrey EF, Bartko JJ, Yolken RH (2012) Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull 38:642\u2013647","journal-title":"Schizophr Bull"},{"key":"413_CR24","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3201\/eid0911.030143","volume":"9","author":"EF Torrey","year":"2003","unstructured":"Torrey EF, Yolken RH (2003) Toxoplasma gondii and schizophrenia. Emerg Infect Dis 9:1375\u20131380","journal-title":"Emerg Infect Dis"},{"key":"413_CR25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/schbul\/17.2.197","volume":"17","author":"T Putten Van","year":"1991","unstructured":"Van Putten T, Marder SR, Wirshing WC, Aravagiri M, Chabert N (1991) Neuroleptic plasma levels. Schizophr Bull 17:197\u2013216","journal-title":"Schizophr Bull"},{"key":"413_CR26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0447.2006.00780.x","volume":"114","author":"HL Wang","year":"2006","unstructured":"Wang HL, Wang GH, Li QY, Shu C, Jiang MS, Guo Y (2006) Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr Scand 114:40\u201348","journal-title":"Acta Psychiatr Scand"},{"key":"413_CR27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1286-4579(01)01459-9","volume":"3","author":"JP Webster","year":"2001","unstructured":"Webster JP (2001) Rats, cats, people and parasites: the impact of latent toxoplasmosis on behaviour. Microbes Infect 3:1037\u20131045","journal-title":"Microbes Infect"},{"key":"413_CR28","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/319221","volume":"32","author":"RH Yolken","year":"2001","unstructured":"Yolken RH, Bachmann S, Ruslanova I, Lillehoj E, Ford G, Torrey EF, Schroeder J (2001) Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clin Infect Dis 32:842\u2013844","journal-title":"Clin Infect Dis"},{"key":"413_CR29","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-3024.2009.01131.x","volume":"31","author":"RH Yolken","year":"2009","unstructured":"Yolken RH, Dickerson FB, Fuller Torrey E (2009) Toxoplasma and schizophrenia. Parasite Immunol 31:706\u2013715","journal-title":"Parasite Immunol"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-013-0413-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-013-0413-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-013-0413-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T10:54:28Z","timestamp":1563188068000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-013-0413-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,15]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["413"],"URL":"https:\/\/doi.org\/10.1007\/s00406-013-0413-4","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,15]]}}}